These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 10841194)

  • 1. Integration of taxanes into primary chemotherapy for squamous cell carcinoma of the head and neck: promise fulfilled?
    Brockstein B
    Curr Opin Oncol; 2000 May; 12(3):221-8. PubMed ID: 10841194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Docetaxel in head and neck cancer: a review.
    Colevas AD; Posner MR
    Am J Clin Oncol; 1998 Oct; 21(5):482-6. PubMed ID: 9781605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docetaxel in squamous cell cancer of the head and neck.
    Posner MR
    Anticancer Drugs; 2001 Feb; 12 Suppl 1():S21-4. PubMed ID: 11340900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Taxoids in head and neck cancer: the American approach.
    Forastiere AA
    Acta Otorhinolaryngol Belg; 1999; 53(3):253-7. PubMed ID: 10635404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of docetaxel in the management of squamous cell cancer of the head and neck.
    Glisson BS
    Oncology (Williston Park); 2002 Jun; 16(6 Suppl 6):83-7. PubMed ID: 12108901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Taxanes in the treatment of head and neck cancer.
    Schrijvers D; Vermorken JB
    Curr Opin Oncol; 2005 May; 17(3):218-24. PubMed ID: 15818164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Docetaxel induction therapy in locally advanced squamous cell carcinoma of the head and neck.
    Posner MR; Lefebvre JL
    Br J Cancer; 2003 Jan; 88(1):11-7. PubMed ID: 12556952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the taxoids and other new agents in head and neck cancer therapy.
    Schrijvers D; Vermorken JB
    Curr Opin Oncol; 1998 May; 10(3):233-41. PubMed ID: 9619360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxanes in cancer of the head and neck.
    Misiukiewicz K; Gupta V; Bakst R; Posner M
    Anticancer Drugs; 2014 May; 25(5):561-70. PubMed ID: 24534821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Phase I/II trial of concurrent docetaxel and radiation after induction chemotherapy in patients with poor prognosis squamous cell carcinoma of the head and neck.
    Tishler RB; Norris CM; Colevas AD; Lamb CC; Karp D; Busse PM; Nixon A; Frankenthaler R; Lake-Willcutt B; Costello R; Case M; Posner MR
    Cancer; 2002 Oct; 95(7):1472-81. PubMed ID: 12237916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction chemotherapy with docetaxel, cisplatin, fluorouracil, and leucovorin for squamous cell carcinoma of the head and neck: a phase I/II trial.
    Colevas AD; Busse PM; Norris CM; Fried M; Tishler RB; Poulin M; Fabian RL; Fitzgerald TJ; Dreyfuss A; Peters ES; Adak S; Costello R; Barton JJ; Posner MR
    J Clin Oncol; 1998 Apr; 16(4):1331-9. PubMed ID: 9552034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Evolving and Future Role of Taxanes in Squamous Cell Carcinomas of the Head and Neck: A Review.
    Mody MD; Gill HS; Saba NF
    JAMA Otolaryngol Head Neck Surg; 2016 Sep; 142(9):898-905. PubMed ID: 27389786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of induction chemotherapy in the curative treatment of squamous cell cancer of the head and neck.
    Posner MR; Colevas AD; Tishler RB
    Semin Oncol; 2000 Aug; 27(4 Suppl 8):13-24. PubMed ID: 10952434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taxanes as radiosensitizers for head and neck cancer.
    Herscher LL; Cook J
    Curr Opin Oncol; 1999 May; 11(3):183-6. PubMed ID: 10328592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced head and neck cancer and clinical experience of an effective new agent: docetaxel.
    Schöffski P; Weihkopf T; Ganser A
    Anticancer Res; 1998; 18(6B):4751-6. PubMed ID: 9891552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Second-line treatment with docetaxel after failure of a platinum-based chemotherapy in squamous-cell head and neck cancer.
    Numico G; Merlano M
    Ann Oncol; 2002 Feb; 13(2):331-3. PubMed ID: 11886014
    [No Abstract]   [Full Text] [Related]  

  • 17. Induction chemotherapy with TPF (Docetaxel, Carboplatin and Fluorouracil) in the treatment of locally advanced squamous cell carcinoma of the head and neck.
    Schultz JD; Bran G; Anders C; Sadick H; Faber A; Hörmann K; Sauter A
    Oncol Rep; 2010 Nov; 24(5):1213-6. PubMed ID: 20878112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Docetaxel and squamous cell carcinoma of the head and neck].
    Calais G
    Bull Cancer; 2004 Feb; 91(2):167-71. PubMed ID: 15047456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II Trial of docetaxel and cisplatin combination chemotherapy in patients with squamous cell carcinoma of the head and neck.
    Glisson BS; Murphy BA; Frenette G; Khuri FR; Forastiere AA
    J Clin Oncol; 2002 Mar; 20(6):1593-9. PubMed ID: 11896109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy in head and neck cancer. Overview of newer agents.
    Khattab J; Urba SG
    Hematol Oncol Clin North Am; 1999 Aug; 13(4):753-68. PubMed ID: 10494511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.